Tru-D Featured in Outpatient Surgery Magazine
In January, St. Charles-Bend brought in Tru-D for a 45-day trial. Satisfied with the results of reducing hospital-acquired infections (HAIs) without impeding room turnovers, the hospital now intends to invest in three more units: one for the ORs; one for patient rooms on the medical floor; and one to be used as a floater where it’s needed most. “A lot of hospitals will shy away from buying high-ticket technology unless it brings in revenue, but this is an exception,” said Randy Barnes. “It has a patient safety benefit and essentially pays for itself.”
Individual hospital results may vary based on numerous factors including adherence to standard disinfection protocol.
Mission Hospital is currently using its Tru-D robots in its 16 ORs as well as in labor and delivery units. Last year, Mission only had one deep-organ SSI among all total hip cases. This is an “extremely significant drop,” according to Wendy Ferro-Grant. There have also been zero surgical site infections out of 330 total knee replacements. While she can’t attribute the sole reason for the drop to Tru-D, she’s confident it played a significant role.
To read the full article, click here.